PrP(106–126) activates neuronal intracellular kinases and Egr1 synthesis through activation of NADPH‐oxidase independently of PrPc
Open Access
- 5 July 2005
- journal article
- Published by Wiley in FEBS Letters
- Vol. 579 (19), 4099-4106
- https://doi.org/10.1016/j.febslet.2005.06.037
Abstract
Prion diseases are characterised by severe neural lesions linked to the presence of an abnormal protease‐resistant isoform of cellular prion protein (PrPc). The peptide PrP(106–126) is widely used as a model of neurotoxicity in prion diseases. Here, we examine in detail the intracellular signalling cascades induced by PrP(106–126) in cortical neurons and the participation of PrPc. We show that PrP(106–126) induces the activation of subsets of intracellular kinases (e.g., ERK1/2), early growth response 1 synthesis and induces caspase‐3 activity, all of which are mediated by nicotinamide adenine dinucleotide phosphate hydrogen‐oxidase activity and oxidative stress. However, cells lacking PrPc are similarly affected after peptide exposure, and this questions the involvement of PrPc in these effects.Keywords
This publication has 53 references indexed in Scilit:
- Interaction of the 106–126 prion peptide with lipid membranes and potential implication for neurotoxicityBiochemical and Biophysical Research Communications, 2005
- The neurotoxicity of prion protein (PrP) peptide 106–126 is independent of the expression level of PrP and is not mediated by abnormal PrP speciesMolecular and Cellular Neuroscience, 2004
- Glycogen synthase kinase 3: a drug target for CNS therapiesJournal of Neurochemistry, 2004
- p38 MAP Kinase Mediates the Cell Death Induced by PrP106–126 in the SH-SY5Y Neuroblastoma CellsNeurobiology of Disease, 2002
- Neurotrophin p75 Receptor Is Involved in Neuronal Damage by Prion Peptide-(106–126)Journal of Biological Chemistry, 2001
- Sublethal Concentrations of Prion Peptide PrP106–126 or the Amyloid Beta Peptide of Alzheimer's Disease Activates Expression of Proapoptotic Markers in Primary Cortical NeuronsNeurobiology of Disease, 2001
- Most Pathogenic Mutations Do Not Alter the Membrane Topology of the Prion ProteinPublished by Elsevier ,2001
- Prion Protein-Deficient Neurons Reveal Lower Glutathione Reductase Activity and Increased Susceptibility to Hydrogen Peroxide ToxicityThe American Journal of Pathology, 1999
- A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in cultureGlia, 1996
- Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragmentNeuroReport, 1994